Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin Prehabituation for Vestibular Schwannoma
NCT02963896Completed
- Sponsor
- Motol University Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
01
Overview
Open-label trial of gentamicin in vestibular schwannoma (VS) (2 arms), sponsored by Motol University Hospital. Primary endpoints: Glasgow Benefit Inventory at 3 years, Glasgow Health Status Inventory at 3 years and 1 more. Started Jan 2014; status: completed.
02
Drugs
gentamicin
03
Conditions
vestibular schwannoma (VS)
Beyond the preview
Go deeper on NCT02963896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02963896.